Used globally for over a decade in 50+ countries, Reveos targets efficiency and bolstering the platelet supply. Lakewood, CO – 17 October 2024 – Terumo Blood and Cell Technologies (Terumo BCT), a ...
LAKEWOOD, Colo., Oct. 22, 2025 /PRNewswire/ -- To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the second U.S. blood center to ...
Reveos is positioned to help U.S. blood centers supplement the platelet supply, reduce labor and costs, and improve overall operational efficiency LAKEWOOD, Colo., Aug. 1, 2023 /PRNewswire/ -- Terumo ...
Terumo Blood and Cell Technologies' Reveos is the first and only system of its kind, now cleared by FDA for the U.S. It aims to help U.S. blood centers supplement the platelet supply, reduce labor and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results